Britain's NHS drugs watchdog has for the first time terminated an assessment of a powerful new cancer medicine because of a row about its price with the manufacturer. The National Institute for Clinical Excellence (Nice), which approves drugs for use on the NHS, is involved in a stand-off with the pharmaceutical company, Roche, which means NHS patients cannot get access to the latest Roche cancer treatment, Avastin.
Link to Article
NHS blocks cancer drug in price row - The Independent 27th June 2008
Tuesday, July 01, 2008
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment